By Abigail Townsend
Date: Monday 23 Feb 2026
(Sharecast News) - Shares in Arcellx soared on Monday, after the US biotech agreed to be taken over by Gilead Sciences in a near $8bn deal.
| Currency | US Dollars |
| Share Price | $ 137.47 |
| Change Today | $ 0.13 |
| % Change | 0.09 % |
| 52 Week High | $155.80 |
| 52 Week Low | $97.07 |
| Volume | 718,866 |
| Shares Issued | 1,241.00m |
| Market Cap | $170,600m |
| Beta | 0.01 |
| RiskGrade | 120 |
| Strong Buy | 10 |
| Buy | 13 |
| Neutral | 5 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 29 |

| Time | Volume / Share Price |
| 10:14 | 100 @ $137.47 |
| 10:14 | 200 @ $137.47 |
| 10:14 | 100 @ $137.47 |
| 10:14 | 100 @ $137.38 |
| 10:13 | 124 @ $137.45 |
You are here: research